Pierre Coliat

A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53

Vania Vidimar, Cynthia Licona, Ricardo Cerón‐Camacho et al. · Cancer Letters · 2018 · 32 citations

Angiogenesis, Hif1 Pathway, Medicine +11

Human Papillomavirus-related tumours of the oropharynx display a lower tumour hypoxia signature

Elodie Hanns, Sylvie Job, Pierre Coliat et al. · Oral Oncology · 2015 · 31 citations · Full text

Cervical Cancer, Oropharynx Display, Medicine +7

Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation

Paul‐Michel Mertès, Olivier Collange, Pierre Coliat et al. · Journal of Controlled Release · 2021 · 20 citations · Full text

Constitutive or Induced HIF-2 Addiction is Involved in Resistance to Anti-EGFR Treatment and Radiation Therapy in HNSCC

Pierre Coliat, Ludivine Ramolu, Jérémie Jegu et al. · Cancers · 2019 · 19 citations · Full text

A Combination of Native LC-MS Approaches for the Comprehensive Characterization of the Antibody-Drug Conjugate Trastuzumab Deruxtecan

Evolène Deslignière, Hélène Diemer, Stéphane Erb et al. · Frontiers in Bioscience-Landmark · 2022 · 16 citations · Full text